These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9894449)

  • 1. The Pap smear, automated rescreening, and negligent nondisclosure.
    Godfrey SE
    Am J Clin Pathol; 1999 Jan; 111(1):14-7. PubMed ID: 9894449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pap smear liability crisis.
    McCoy DR; Sidoti MS
    Am J Clin Pathol; 1999 Aug; 112(2):274-80. PubMed ID: 10439810
    [No Abstract]   [Full Text] [Related]  

  • 3. The standard of care in cytopathology.
    Gatter K
    Am J Clin Pathol; 1999 Aug; 112(2):273-4. PubMed ID: 10439809
    [No Abstract]   [Full Text] [Related]  

  • 4. Pap smear liability: do computer-assisted rescreening devices affect the standard of care?
    Bierig JR; Weber SA
    CAP Today; 1997 Apr; 11(4):32-4. PubMed ID: 10174223
    [No Abstract]   [Full Text] [Related]  

  • 5. Automated Papanicolaou smear analysis as a screening tool for female lower genital tract malignancies.
    Ku NN
    Curr Opin Obstet Gynecol; 1999 Feb; 11(1):41-3. PubMed ID: 10047962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
    Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for automated cytology.
    Richart RM; Patten SF; Lee JS
    Obstet Gynecol Clin North Am; 1996 Dec; 23(4):853-9. PubMed ID: 8989778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A smear on audit. Implications of the Leicester cervical smear audit.
    Symonds P; Naftalin N; Shaw P
    BJOG; 2003 Jul; 110(7):646-8. PubMed ID: 12842054
    [No Abstract]   [Full Text] [Related]  

  • 9. Are Current Tort Liability Doctrines Adequate for Addressing Injury Caused by AI?
    Sullivan HR; Schweikart SJ
    AMA J Ethics; 2019 Feb; 21(2):E160-166. PubMed ID: 30794126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated cytologic screening devices and malpractice liability.
    Skoumal SM; Cohen MB
    Diagn Cytopathol; 1997 Aug; 17(2):85-7. PubMed ID: 9258613
    [No Abstract]   [Full Text] [Related]  

  • 11. College of American Pathologists Conference XXX on quality and liability issues with the Papanicolaou smear: summation.
    Austin RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):341-2. PubMed ID: 9111131
    [No Abstract]   [Full Text] [Related]  

  • 12. A decade has passed...the Pap smear and cervical cancer.
    Linder J
    Am J Clin Pathol; 1997 Nov; 108(5):492-8. PubMed ID: 9353086
    [No Abstract]   [Full Text] [Related]  

  • 13. HPV: from the cervical smear to the research bench to the court room.
    Atkins K
    Clin Leadersh Manag Rev; 2003; 17(6):341-5. PubMed ID: 14692078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated rescreening in cervical cytology. Mathematical models for evaluating overall process sensitivity, specificity and cost.
    Kaminsky FC; Benneyan JC; Mullins DL
    Acta Cytol; 1997; 41(1):209-23. PubMed ID: 9022745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality and liability issues with the Papanicolaou smear.
    Sirota RL
    Arch Pathol Lab Med; 1997 Dec; 121(12):1237-8. PubMed ID: 9431309
    [No Abstract]   [Full Text] [Related]  

  • 17. Automated screening of cervical cytology specimens.
    Birdsong GG
    Hum Pathol; 1996 May; 27(5):468-81. PubMed ID: 8621186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicolegal implications of colon cancer screening.
    Feld AD
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):171-9, viii-ix. PubMed ID: 11916158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural network processing can provide means to catch errors that slip through human screening of pap smears.
    Boon ME; Kok LP
    Diagn Cytopathol; 1993 Aug; 9(4):411-6. PubMed ID: 8261846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pap smears: physicians must disclose risk of refusal.
    Annas GJ
    Nurs Law Ethics; 1981 Jan; 2(1):3. PubMed ID: 12085919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.